HEADER HORMONE/GROWTH FACTOR 22-SEP-04 1XJ7 TITLE COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANDROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN(LBD); COMPND 5 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RAC3 DERIVED PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS ANDROGEN RECEPTOR COACTIVATORS LXXLL MOTIF, HORMONE-GROWTH FACTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.ESTEBANEZ-PERPINA,J.M.R.MOORE,E.MAR,P.NGUYEN,E.DELGADO-RODRIGUES, AUTHOR 2 J.D.BAXTER,B.M.BUEHRER,P.WEBB,R.J.FLETTERICK,R.K.GUY REVDAT 5 13-MAR-24 1XJ7 1 REMARK REVDAT 4 11-OCT-17 1XJ7 1 REMARK REVDAT 3 24-FEB-09 1XJ7 1 VERSN REVDAT 2 22-MAR-05 1XJ7 1 JRNL REVDAT 1 25-JAN-05 1XJ7 0 JRNL AUTH E.ESTEBANEZ-PERPINA,J.M.R.MOORE,E.MAR,E.DELGADO-RODRIGUES, JRNL AUTH 2 P.NGUYEN,J.D.BAXTER,B.M.BUEHRER,P.WEBB,R.J.FLETTERICK, JRNL AUTH 3 R.K.GUY JRNL TITL THE MOLECULAR MECHANISMS OF COACTIVATOR UTILIZATION IN JRNL TITL 2 LIGAND-DEPENDENT TRANSACTIVATION BY THE ANDROGEN RECEPTOR JRNL REF J.BIOL.CHEM. V. 280 8060 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15563469 JRNL DOI 10.1074/JBC.M407046200 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 9782 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.320 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 31 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2172 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.58 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XJ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1000030414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ELVES REMARK 200 DATA SCALING SOFTWARE : ELVES REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 48.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA-CITRATE, HEPES, PH 8.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.52900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.53850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.41550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.53850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.52900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.41550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 919 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 664 87.32 -60.27 REMARK 500 TYR A 667 -16.79 -174.04 REMARK 500 CYS A 669 155.31 66.86 REMARK 500 GLN A 670 -24.15 97.70 REMARK 500 VAL A 676 -71.30 -55.08 REMARK 500 ASN A 692 36.69 -75.67 REMARK 500 ALA A 698 -70.31 -72.04 REMARK 500 LEU A 700 -74.47 -61.03 REMARK 500 TYR A 739 -72.14 -103.97 REMARK 500 SER A 740 1.02 -63.03 REMARK 500 ASN A 756 -91.45 -96.89 REMARK 500 SER A 759 84.01 42.13 REMARK 500 ARG A 760 -29.06 -165.64 REMARK 500 SER A 782 -70.87 -49.67 REMARK 500 PHE A 813 47.29 -97.45 REMARK 500 ILE A 815 107.89 -170.98 REMARK 500 ASN A 823 68.68 178.72 REMARK 500 CYS A 844 70.60 -151.23 REMARK 500 LYS A 845 -25.72 -167.11 REMARK 500 ASN A 848 109.68 -170.57 REMARK 500 PRO A 849 36.51 -67.41 REMARK 500 ILE A 882 -71.37 -65.99 REMARK 500 LYS A 883 26.98 -74.59 REMARK 500 SER A 884 -77.40 -53.30 REMARK 500 MET A 886 -70.55 -52.60 REMARK 500 VAL A 901 -64.06 -122.61 REMARK 500 HIS A 917 -141.19 -92.83 REMARK 500 LYS B 921 -55.27 -152.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DHT A 931 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T5Z RELATED DB: PDB REMARK 900 AR LBD AND ARA70 PEPTIDE REMARK 900 RELATED ID: 1T63 RELATED DB: PDB REMARK 900 AR LBD AND SRC2-3 PEPTIDE REMARK 900 RELATED ID: 1T65 RELATED DB: PDB REMARK 900 AR LBD AND SRC2-2 PEPTIDE DBREF 1XJ7 A 663 919 UNP P10275 ANDR_HUMAN 663 919 DBREF 1XJ7 B 920 928 PDB 1XJ7 1XJ7 920 928 SEQRES 1 A 257 HIS ILE GLU GLY TYR GLU CYS GLN PRO ILE PHE LEU ASN SEQRES 2 A 257 VAL LEU GLU ALA ILE GLU PRO GLY VAL VAL CYS ALA GLY SEQRES 3 A 257 HIS ASP ASN ASN GLN PRO ASP SER PHE ALA ALA LEU LEU SEQRES 4 A 257 SER SER LEU ASN GLU LEU GLY GLU ARG GLN LEU VAL HIS SEQRES 5 A 257 VAL VAL LYS TRP ALA LYS ALA LEU PRO GLY PHE ARG ASN SEQRES 6 A 257 LEU HIS VAL ASP ASP GLN MET ALA VAL ILE GLN TYR SER SEQRES 7 A 257 TRP MET GLY LEU MET VAL PHE ALA MET GLY TRP ARG SER SEQRES 8 A 257 PHE THR ASN VAL ASN SER ARG MET LEU TYR PHE ALA PRO SEQRES 9 A 257 ASP LEU VAL PHE ASN GLU TYR ARG MET HIS LYS SER ARG SEQRES 10 A 257 MET TYR SER GLN CYS VAL ARG MET ARG HIS LEU SER GLN SEQRES 11 A 257 GLU PHE GLY TRP LEU GLN ILE THR PRO GLN GLU PHE LEU SEQRES 12 A 257 CYS MET LYS ALA LEU LEU LEU PHE SER ILE ILE PRO VAL SEQRES 13 A 257 ASP GLY LEU LYS ASN GLN LYS PHE PHE ASP GLU LEU ARG SEQRES 14 A 257 MET ASN TYR ILE LYS GLU LEU ASP ARG ILE ILE ALA CYS SEQRES 15 A 257 LYS ARG LYS ASN PRO THR SER CYS SER ARG ARG PHE TYR SEQRES 16 A 257 GLN LEU THR LYS LEU LEU ASP SER VAL GLN PRO ILE ALA SEQRES 17 A 257 ARG GLU LEU HIS GLN PHE THR PHE ASP LEU LEU ILE LYS SEQRES 18 A 257 SER HIS MET VAL SER VAL ASP PHE PRO GLU MET MET ALA SEQRES 19 A 257 GLU ILE ILE SER VAL GLN VAL PRO LYS ILE LEU SER GLY SEQRES 20 A 257 LYS VAL LYS PRO ILE TYR PHE HIS THR GLN SEQRES 1 B 9 HIS LYS LYS LEU LEU GLN LEU LEU THR HET DHT A 931 21 HETNAM DHT 5-ALPHA-DIHYDROTESTOSTERONE FORMUL 3 DHT C19 H30 O2 FORMUL 4 HOH *167(H2 O) HELIX 1 1 GLN A 670 ILE A 680 1 11 HELIX 2 2 SER A 696 LEU A 722 1 27 HELIX 3 3 GLY A 724 LEU A 728 5 5 HELIX 4 4 HIS A 729 ASN A 756 1 28 HELIX 5 5 ASN A 771 SER A 778 1 8 HELIX 6 6 MET A 780 LEU A 797 1 18 HELIX 7 7 THR A 800 PHE A 813 1 14 HELIX 8 8 ASN A 823 ALA A 843 1 21 HELIX 9 9 THR A 850 SER A 865 1 16 HELIX 10 10 SER A 865 LYS A 883 1 19 HELIX 11 11 LYS A 883 SER A 888 1 6 HELIX 12 12 PRO A 892 VAL A 901 1 10 HELIX 13 13 VAL A 901 SER A 908 1 8 SHEET 1 A 2 LEU A 762 ALA A 765 0 SHEET 2 A 2 LEU A 768 PHE A 770 -1 O LEU A 768 N ALA A 765 SHEET 1 B 2 ILE A 815 PRO A 817 0 SHEET 2 B 2 VAL A 911 PRO A 913 -1 O LYS A 912 N ILE A 816 SITE 1 AC1 7 LEU A 704 ASN A 705 LEU A 707 MET A 749 SITE 2 AC1 7 ARG A 752 PHE A 764 THR A 877 CRYST1 53.058 66.831 71.077 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018847 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014963 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014069 0.00000